Clinical Trial Update: Prospective Analysis of Urine LAM to Eliminate NTM Sputum Screening

View source ↗

Summary

A prospective study in cystic fibrosis examines using urine LAM testing to eliminate the need for sputum screening for nontuberculous mycobacteria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Jerry A. Nick, M.D. | Conditions: Cystic Fibrosis | Status: ENROLLING_BY_INVITATION